March 29, 2017 / 1:08 AM / 5 months ago

BRIEF-FDA approves Genentech's MS drug Ocrevus

March 28 (Reuters) - Roche Holding Ag

* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis

* Ocrevus will be available to people in U.S. within two weeks

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below